Opinion · 9 Jul 2025
Conference abstractPublished 18 Jul 2018
Sigma-2 (σ2) receptor ligands as potential anticancer agents for pancreatic cancer
Florida Agricultural and Mechanical University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic cancer is the fourth leading cause of cancer-related mortality amongst all cancers. The overall 5-year survival rate is 6% and the total cost of treatment is estimated to be 4.9 billion dollars per year in the United States. One major obstacle in the treatment of cancer is the development of selective chemotherapeutic agents. Sigma receptors, particularly the sigma-2 subtype, have emerged as an interesting target for the design of treatments for various cancers. They are overexpressed in rapidly proliferating cancer cells. Hence, sigma-2 receptor ligands may represent a platform for chemotherapeutics of pancreatic and other types of cancers. We recently synthesized a series of modified compounds and determined their affinity to various receptors. Binding studies show that compound 23 favorably interacts with sigma-2 receptors (Ki = 2.7 nM). Evaluation of the cytotoxic effects of these compounds on various pancreatic cancer cell lines is ongoing.
Subjects
ChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Organic Chemistry: Current Research.
Commentary · 1 Jul 2025
Cross-Coupling and Chemical Bond Formation of Organotrifluoroborate Nucleophiles in Chemistry
Opinion · 1 Jul 2025
Activation Energy and Reaction Kinetics of Ethyl Acetate Neutral Hydrolysis
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOrganic Chemistry: Current Research
- SubjectChemistry
- BylineArticles whose byline prints “Lamya Alghanim”
